MarketPeel
Insider Trading Intelligence
SL

Svetlana Lucas

JSPR
DIRECTOR · JASPER THERAPEUTICS, INC. · CIK 0001781292
FILING MIX · LIFETIME92%/8%
BUYS
12
SELLS
1
TOTAL VALUE
$48.6K
COMPANIES
3
ACTIVE SINCE
May 2020
HOLDINGS NOW
94,000
AVG SELL PX
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Svetlana Lucas, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%-1.97%-0.47%-1.50%-1.50%
14d2+0.00%-5.51%+0.71%-6.23%-6.23%
30d2+0.00%-5.51%+0.14%-5.66%-5.66%
60d2+0.00%-33.07%-1.17%-31.90%-31.90%
90d2+0.00%-24.80%+2.70%-27.50%-27.50%
180d2+0.00%-51.58%-2.74%-48.84%-48.84%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
JSPR · 20,000 shares · as of Sep 22, 2025
05,00010,00015,00020,0002025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 1 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ATYR
ATYR PHARMA INC
PURCHASEGRANT
Stock grant
50,00050,000May 11, 2026May 13, 2026View →
JSPR
JASPER THERAPEUTICS, INC.
PURCHASE
20,000$2.43$48.6K20,000Sep 22, 2025Sep 24, 2025View →
JSPR
JASPER THERAPEUTICS, INC.
PURCHASE
20,00020,000Sep 22, 2025Sep 24, 2025View →
JSPR
JASPER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,5007,500Jul 3, 2025Jul 3, 2025View →
ATYR
ATYR PHARMA INC
PURCHASEGRANT
Stock grant
50,00050,000May 1, 2025May 2, 2025View →
JSPR
JASPER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 18, 2024Jun 20, 2024View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
24,00024,000May 22, 2024May 23, 2024View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
12,00012,000May 17, 2023May 19, 2023View →
LIFE
ETHOS TECHNOLOGIES INC.
SALE
6,0000Apr 26, 2023Apr 28, 2023View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASE
6,0006,000Apr 26, 2023Apr 28, 2023View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
6,0006,000Apr 26, 2022Apr 28, 2022View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
1,4281,428Apr 28, 2021Apr 29, 2021View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
1,4281,428May 6, 2020May 8, 2020View →
Other insiders · JSPR
Loading peer insiders…
About this filer
CIK 0001781292
ROLE
Director
PRIMARY
JSPR
COMPANIES
3
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001781292DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback